Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.
Craif has raised $2.1M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2025.
Craif's investors include ANRI, Global Brain Corporation, Aozora Corporate Investment, Daiwa Corporate Investment, NEDO.
Craif is headquartered in Tokyo, Japan.
Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.
Craif is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Craif — Funding & Investors." VCBacked, April 28, 2025, https://www.vcbacked.co/company/craif. Accessed September 30, 2026.
VCBacked. (2025). Craif — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/craif
{{cite web |title=Craif — Funding & Investors |url=https://www.vcbacked.co/company/craif |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated